Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions
Standard
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions. / Oing, Christoph; Skowron, M A; Bokemeyer, Carsten; Nettersheim, D.
in: ANDROLOGY-US, Jahrgang 2019, Nr. 4, 07.2019, S. 487497.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
Oing, C, Skowron, MA, Bokemeyer, C & Nettersheim, D 2019, 'Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions', ANDROLOGY-US, Jg. 2019, Nr. 4, S. 487497.
APA
Oing, C., Skowron, M. A., Bokemeyer, C., & Nettersheim, D. (2019). Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions. ANDROLOGY-US, 2019(4), 487497.
Vancouver
Oing C, Skowron MA, Bokemeyer C, Nettersheim D. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions. ANDROLOGY-US. 2019 Jul;2019(4):487497.
Bibtex
@article{569dc4ea02934a638b054fdb133ffcb4,
title = "Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions",
author = "Christoph Oing and Skowron, {M A} and Carsten Bokemeyer and D. Nettersheim",
year = "2019",
month = jul,
language = "Deutsch",
volume = "2019",
pages = "487497",
journal = "ANDROLOGY-US",
issn = "2047-2919",
publisher = "John Wiley and Sons Inc.",
number = "4",
}
RIS
TY - JOUR
T1 - Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors-past, presentand future considerataions
AU - Oing, Christoph
AU - Skowron, M A
AU - Bokemeyer, Carsten
AU - Nettersheim, D.
PY - 2019/7
Y1 - 2019/7
M3 - SCORING: Review
VL - 2019
SP - 487497
JO - ANDROLOGY-US
JF - ANDROLOGY-US
SN - 2047-2919
IS - 4
ER -
